偏向G蛋白结合受体激动剂的合理设计
1Department of Pharmacology, Vanderbilt University, Nashville, Tennessee.
Molecular pharmacology
|December 5, 2025
概括
为G蛋白结合受体 (GPCRs) 设计偏向体,需要将GPCR-G蛋白复合体与GPCR-GPCR激酶 (GRK) 复合体进行比较. 这种方法,而不是与GPCR-arrestin复合体进行比较,指导着向信号疗法的开发.
科学领域:
- 药理学 药理学是指药理学的学科.
- 生物化学 生化学
- 分子生物学分子生物学
背景情况:
- G蛋白结合受体 (GPCRs) 激活多个信号通路.
- 一些GPCR信号通路提供治疗益处,而另一些则导致不良影响.
- 偏差配体旨在选择性地激活所需的通路,最大限度地减少不必要的副作用.
研究的目的:
- 为了研究设计针对特定GPCR信号通路的偏向配体的结构基础.
- 确定最优的比较点,以指导偏向GPCR配体的合理设计.
主要方法:
- 对GPCR信号传递,酸化和带偏差的现有数据的分析.
- 将GPCR-G蛋白质复合体结构与GPCR-GPCR激酶 (GRK) 和GPCR-arrestin复合体进行比较.
- 考虑GRK作为关门人来阻止中介信号的作用.
主要成果:
- 对GPCRs的阿雷斯丁招募取决于GRKs先前的酸化.
- GPCRs可以参与不同的GRK亚型,引入额外的一层信号偏差.
- 将GPCR-G蛋白质复合体与GPCR-GRK复合体进行比较对于设计有偏差的配体至关重要.
结论:
- 偏向的GPCR配体的合理设计应侧重于GPCR-GRK相互作用,而不是GPCR-arrestin相互作用.
- 了解GRKs对GPCR的酸化是实现选择性G蛋白或阿雷斯通路调节的关键.
- 这种比较的结构方法可以指导新疗法的开发,以提高疗效和安全性.
相关概念视频
G Protein-coupled Receptors
16.3K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
16.3K
Transducer Mechanism: G Protein–Coupled Receptors
3.9K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
GPCRs are also called heptahelical,...
3.9K
The Two-State Receptor Model
3.0K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
3.0K
Drug-Receptor Interaction: Agonist
3.7K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
3.7K
G-protein Coupled Receptors
131.3K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
131.3K
GPCRs Regulate Adenylyl Cylase Activity
7.2K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
7.2K


